HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$56.78
Day range
$56.39 - $57.41
Year range
$20.98 - $62.40
Market cap
9.55B USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 162.34M | 41.05% |
Net income | -156.29M | -44.13% |
Net profit margin | — | — |
Earnings per share | -0.94 | 5.05% |
EBITDA | -174.10M | -42.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.55B | 90.54% |
Total assets | 1.76B | 79.12% |
Total liabilities | 196.70M | 34.01% |
Total equity | 1.57B | — |
Shares outstanding | 168.22M | — |
Price to book | 6.08 | — |
Return on assets | -24.60% | — |
Return on capital | -26.15% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -156.29M | -44.13% |
Cash from operations | -130.42M | -29.77% |
Cash from investing | -21.47M | -127.75% |
Cash from financing | 77.29M | 7,545.30% |
Net change in cash | -74.59M | -237.01% |
Free cash flow | -79.86M | -45.27% |
About
Founded
2014
Headquarters
Website
Employees
490